{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:20:46Z","timestamp":1793910046339,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["Pa-CSC 233460"],"award-info":[{"award-number":["Pa-CSC 233460"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","award":["CAM-PaC"],"award-info":[{"award-number":["CAM-PaC"]}],"id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione del Piemonte per l\u2019Oncologia \u2013 IRCCS","award":["PTCRC-Intra-2021"],"award-info":[{"award-number":["PTCRC-Intra-2021"]}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["2021-01-07-00-02-E00090"],"award-info":[{"award-number":["2021-01-07-00-02-E00090"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130074"],"award-info":[{"award-number":["82130074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902673"],"award-info":[{"award-number":["81902673"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2314-B-039-056"],"award-info":[{"award-number":["111-2314-B-039-056"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Pujiang Program","award":["21PJ1408900"],"award-info":[{"award-number":["21PJ1408900"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is a profoundly aggressive and fatal cancer. One of the key factors defining its aggressiveness and resilience against chemotherapy is the existence of cancer stem cells (CSCs). The important task of discovering upstream regulators of stemness that are amenable for targeting in PDAC is essential for the advancement of more potent therapeutic approaches. In this study, we sought to elucidate the function of the nuclear receptor subfamily 5, group A, member 2 (NR5A2) in the context of pancreatic CSCs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We modeled human PDAC using primary PDAC cells and CSC-enriched sphere cultures. NR5A2 was genetically silenced or inhibited with Cpd3. Assays included RNA-seq, sphere\/colony formation, cell viability\/toxicity, real-time PCR, western blot, immunofluorescence, ChIP, CUT&amp;Tag, XF Analysis, lactate production, and in vivo tumorigenicity assays. PDAC models from 18 patients were treated with Cpd3-loaded nanocarriers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our findings demonstrate that NR5A2 plays a dual role in PDAC. In differentiated cancer cells, NR5A2 promotes cell proliferation by inhibiting CDKN1A. On the other hand, in the CSC population, NR5A2 enhances stemness by upregulating SOX2 through direct binding to its promotor\/enhancer region. Additionally, NR5A2 suppresses MYC, leading to the activation of the mitochondrial biogenesis factor PPARGC1A and a shift in metabolism towards oxidative phosphorylation, which is a crucial feature of stemness in PDAC. Importantly, our study shows that the specific NR5A2 inhibitor, Cpd3, sensitizes a significant fraction of PDAC models derived from 18 patients to standard chemotherapy. This treatment approach results in durable remissions and long-term survival. Furthermore, we demonstrate that the expression levels of NR5A2\/SOX2 can predict the response to treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The findings of our study highlight the cell context-dependent effects of NR5A2 in PDAC. We have identified a novel pharmacological strategy to modulate SOX2 and MYC levels, which disrupts stemness and prevents relapse in this deadly disease. These insights provide valuable information for the development of targeted therapies for PDAC, offering new hope for improved patient outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                <jats:p><jats:bold>A<\/jats:bold>\u00a0Schematic illustration of the role of NR5A2 in cancer stem cells versus differentiated cancer cells, along with the action of the NR5A2 inhibitor Cpd3. <jats:bold>B<\/jats:bold>\u00a0Overall survival of tumor-bearing mice following allocated treatment. A total of 18 PDX models were treated using a 2 x 1 x 1 approach (two animals per model per treatment); n=36 per group (illustration created with <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.biorender.com\/\">biorender.com<\/jats:ext-link>).<\/jats:p>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13046-023-02883-y","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T04:42:52Z","timestamp":1701146572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2\/MYC signaling and restoring chemosensitivity"],"prefix":"10.1186","volume":"42","author":[{"given":"Quan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Aicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Bou Kheir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berina","family":"Sabanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeta","family":"Ananthanarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Reina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Min","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Alcala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita T.","family":"Lawlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Bruno","family":"Sainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1092-5395","authenticated-orcid":false,"given":"Patricia","family":"Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1158-8554","authenticated-orcid":false,"given":"Christopher","family":"Heeschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"issue":"6","key":"2883_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","volume":"15","author":"JP Neoptolemos","year":"2018","unstructured":"Neoptolemos JP, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer DH. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 2018;15(6):333\u201348.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"2883_CR2","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S2468-1253(19)30347-4","volume":"4","author":"Collaborators GBDPC","year":"2019","unstructured":"Collaborators GBDPC. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):934\u201347.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"19","key":"2883_CR3","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817\u201325.","journal-title":"N Engl J Med"},{"issue":"1","key":"2883_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"18","key":"2883_CR5","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369(18):1691\u2013703.","journal-title":"N Engl J Med"},{"issue":"11","key":"2883_CR6","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913\u201321.","journal-title":"Cancer Res"},{"issue":"3","key":"2883_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1(3):313\u201323.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"2883_CR8","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","volume":"67","author":"C Li","year":"2007","unstructured":"Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67(3):1030\u20137.","journal-title":"Cancer Res"},{"issue":"11","key":"2883_CR9","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/nmeth.3112","volume":"11","author":"I Miranda-Lorenzo","year":"2014","unstructured":"Miranda-Lorenzo I, Dorado J, Lonardo E, Alcala S, Serrano AG, Clausell-Tormos J, et al. Intracellular autofluorescence: a biomarker for epithelial cancer stem cells. Nat Methods. 2014;11(11):1161\u20139.","journal-title":"Nat Methods"},{"issue":"4","key":"2883_CR10","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/cancers15041053","volume":"15","author":"GC Eptaminitaki","year":"2023","unstructured":"Eptaminitaki GC, Zaravinos A, Stellas D, Panagopoulou M, Karaliota S, Baltsavia I, et al. Genome-wide analysis of lncRNA-mRNA Co-expression networks in CD133+\/CD44+ stem-like PDAC cells. Cancers (Basel). 2023;15(4):1053.","journal-title":"Cancers (Basel)"},{"issue":"34","key":"2883_CR11","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1038\/onc.2014.382","volume":"34","author":"S Bianco","year":"2015","unstructured":"Bianco S, Jangal M, Garneau D, Gevry N. LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression. Oncogene. 2015;34(34):4509\u201318.","journal-title":"Oncogene"},{"issue":"10","key":"2883_CR12","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1158\/1078-0432.CCR-14-1399","volume":"21","author":"M Cioffi","year":"2015","unstructured":"Cioffi M, Trabulo S, Hidalgo M, Costello E, Greenhalf W, Erkan M, et al. Inhibition of CD47 effectively targets pancreatic cancer stem cells via dual mechanisms. Clin Cancer Res. 2015;21(10):2325\u201337.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2883_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1055\/s-0030-1253225","volume":"30","author":"M Wagner","year":"2010","unstructured":"Wagner M, Zollner G, Trauner M. Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis. Semin Liver Dis. 2010;30(2):160\u201377.","journal-title":"Semin Liver Dis"},{"issue":"10","key":"2883_CR14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00018-008-7552-1","volume":"65","author":"I D'Errico","year":"2008","unstructured":"D\u2019Errico I, Moschetta A. Nuclear receptors, intestinal architecture and colon cancer: an intriguing link. Cell Mol Life Sci. 2008;65(10):1523\u201343.","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"2883_CR15","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/stem.502","volume":"28","author":"RT Wagner","year":"2010","unstructured":"Wagner RT, Xu X, Yi F, Merrill BJ, Cooney AJ. Canonical Wnt\/beta-catenin regulation of liver receptor homolog-1 mediates pluripotency gene expression. Stem Cells. 2010;28(10):1794\u2013804.","journal-title":"Stem Cells"},{"issue":"41","key":"2883_CR16","doi-asserted-by":"publisher","first-page":"16927","DOI":"10.1073\/pnas.1112047108","volume":"108","author":"C Benod","year":"2011","unstructured":"Benod C, Vinogradova MV, Jouravel N, Kim GE, Fletterick RJ, Sablin EP. Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation. Proc Natl Acad Sci U S A. 2011;108(41):16927\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2883_CR17","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1136\/gutjnl-2012-304287","volume":"63","author":"G von Figura","year":"2014","unstructured":"von Figura G, Morris JPt, Wright CV, Hebrok M. Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation. Gut. 2014;63(4):656\u201364.","journal-title":"Gut"},{"issue":"27","key":"2883_CR18","doi-asserted-by":"publisher","first-page":"19830","DOI":"10.1074\/jbc.M112.411686","volume":"288","author":"C Benod","year":"2013","unstructured":"Benod C, Carlsson J, Uthayaruban R, Hwang P, Irwin JJ, Doak AK, et al. Structure-based discovery of antagonists of nuclear receptor LRH-1. J Biol Chem. 2013;288(27):19830\u201344.","journal-title":"J Biol Chem"},{"key":"2883_CR19","doi-asserted-by":"publisher","first-page":"32638","DOI":"10.1038\/srep32638","volume":"6","author":"SP Duggan","year":"2016","unstructured":"Duggan SP, Behan FM, Kirca M, Zaheer A, McGarrigle SA, Reynolds JV, et al. The characterization of an intestine-like genomic signature maintained during Barrett\u2019s-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival. Sci Rep. 2016;6:32638.","journal-title":"Sci Rep"},{"issue":"1","key":"2883_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ydbio.2016.07.019","volume":"418","author":"S Nissim","year":"2016","unstructured":"Nissim S, Weeks O, Talbot JC, Hedgepeth JW, Wucherpfennig J, Schatzman-Bone S, et al. Iterative use of nuclear receptor Nr5a2 regulates multiple stages of liver and pancreas development. Dev Biol. 2016;418(1):108\u201323.","journal-title":"Dev Biol"},{"issue":"2","key":"2883_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1158\/1535-7163.MCT-08-0924","volume":"8","author":"A Jimeno","year":"2009","unstructured":"Jimeno A, Feldmann G, Suarez-Gauthier A, Rasheed Z, Solomon A, Zou GM, et al. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol Cancer Ther. 2009;8(2):310\u20134.","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"2883_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.stem.2011.10.001","volume":"9","author":"E Lonardo","year":"2011","unstructured":"Lonardo E, Hermann PC, Mueller MT, Huber S, Balic A, Miranda-Lorenzo I, et al. Nodal\/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell Stem Cell. 2011;9(5):433\u201346.","journal-title":"Cell Stem Cell"},{"key":"2883_CR23","volume":"100","author":"E Lonardo","year":"2015","unstructured":"Lonardo E, Cioffi M, Sancho P, Crusz S, Heeschen C. Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies. J Vis Exp. 2015;100: e52801.","journal-title":"J Vis Exp"},{"issue":"9","key":"2883_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng J, Sun BF, Chen CY, Zhou JY, Chen YS, Chen H, et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 2019;29(9):725\u201338.","journal-title":"Cell Res"},{"issue":"6","key":"2883_CR25","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1053\/j.gastro.2016.08.040","volume":"151","author":"P Jandaghi","year":"2016","unstructured":"Jandaghi P, Najafabadi HS, Bauer AS, Papadakis AI, Fassan M, Hall A, et al. Expression of DRD2 is increased in human pancreatic ductal adenocarcinoma and inhibitors slow tumor growth in mice. Gastroenterology. 2016;151(6):1218\u201331.","journal-title":"Gastroenterology"},{"issue":"D1","key":"2883_CR26","doi-asserted-by":"publisher","first-page":"D596","DOI":"10.1093\/nar\/gkab1020","volume":"50","author":"M Li","year":"2022","unstructured":"Li M, Zhang X, Ang KS, Ling J, Sethi R, Lee NYS, et al. DISCO: a database of deeply Integrated human single-cell omics data. Nucleic Acids Res. 2022;50(D1):D596\u2013602.","journal-title":"Nucleic Acids Res"},{"issue":"1\u20132","key":"2883_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.canlet.2014.04.017","volume":"350","author":"Q Lin","year":"2014","unstructured":"Lin Q, Aihara A, Chung W, Li Y, Chen X, Huang Z, et al. LRH1 promotes pancreatic cancer metastasis. Cancer Lett. 2014;350(1\u20132):15\u201324.","journal-title":"Cancer Lett"},{"key":"2883_CR28","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.2147\/CMAR.S162887","volume":"10","author":"L Xiao","year":"2018","unstructured":"Xiao L, Wang Y, Liang W, Liu L, Pan N, Deng H, et al. LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21. Cancer Manag Res. 2018;10:2389\u2013400.","journal-title":"Cancer Manag Res"},{"key":"2883_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2013.23","volume":"2","author":"M Herreros-Villanueva","year":"2013","unstructured":"Herreros-Villanueva M, Zhang JS, Koenig A, Abel EV, Smyrk TC, Bamlet WR, et al. SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis. 2013;2: e61.","journal-title":"Oncogenesis"},{"issue":"4","key":"2883_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","volume":"22","author":"P Sancho","year":"2015","unstructured":"Sancho P, Burgos-Ramos E, Tavera A, Bou Kheir T, Jagust P, Schoenhals M, et al. MYC\/PGC-1alpha balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells. Cell Metab. 2015;22(4):590\u2013605.","journal-title":"Cell Metab"},{"issue":"11","key":"2883_CR31","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/nm.3954","volume":"21","author":"H Gao","year":"2015","unstructured":"Gao H, Korn JM, Ferretti S, Monahan JE, Wang Y, Singh M, et al. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nat Med. 2015;21(11):1318\u201325.","journal-title":"Nat Med"},{"issue":"5","key":"2883_CR32","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/mc.22604","volume":"56","author":"Z Luo","year":"2017","unstructured":"Luo Z, Li Y, Zuo M, Liu C, Tian W, Yan D, et al. Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial-mesenchymal transition (EMT) markers. Mol Carcinog. 2017;56(5):1438\u201348.","journal-title":"Mol Carcinog"},{"issue":"1","key":"2883_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.canlet.2013.11.014","volume":"345","author":"Q Lin","year":"2014","unstructured":"Lin Q, Aihara A, Chung W, Li Y, Huang Z, Chen X, et al. LRH1 as a driving factor in pancreatic cancer growth. Cancer Lett. 2014;345(1):85\u201390.","journal-title":"Cancer Lett"},{"issue":"3","key":"2883_CR34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/ng.522","volume":"42","author":"GM Petersen","year":"2010","unstructured":"Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010;42(3):224\u20138.","journal-title":"Nat Genet"},{"issue":"7693","key":"2883_CR35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nature25751","volume":"554","author":"I Cobo","year":"2018","unstructured":"Cobo I, Martinelli P, Flandez M, Bakiri L, Zhang M, Carrillo-de-Santa-Pau E, et al. Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas. Nature. 2018;554(7693):533\u20137.","journal-title":"Nature"},{"issue":"4","key":"2883_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.molcel.2004.07.009","volume":"15","author":"OA Botrugno","year":"2004","unstructured":"Botrugno OA, Fayard E, Annicotte JS, Haby C, Brennan T, Wendling O, et al. Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell. 2004;15(4):499\u2013509.","journal-title":"Mol Cell"},{"issue":"Pt 1","key":"2883_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2019.08.007","volume":"67","author":"D Novak","year":"2020","unstructured":"Novak D, Huser L, Elton JJ, Umansky V, Altevogt P, Utikal J. SOX2 in development and cancer biology. Semin Cancer Biol. 2020;67(Pt 1):74\u201382.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"2883_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41374-019-0336-4","volume":"100","author":"N Lopes","year":"2020","unstructured":"Lopes N, Bergsland CH, Bjornslett M, Pellinen T, Svindland A, Nesbakken A, et al. Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2. Lab Invest. 2020;100(1):120\u201334.","journal-title":"Lab Invest"},{"issue":"10","key":"2883_CR39","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/ng.2405","volume":"44","author":"CM Rudin","year":"2012","unstructured":"Rudin CM, Durinck S, Stawiski EW, Poirier JT, Modrusan Z, Shames DS, et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet. 2012;44(10):1111\u20136.","journal-title":"Nat Genet"},{"issue":"1","key":"2883_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-020-00242-3","volume":"5","author":"S Zhang","year":"2020","unstructured":"Zhang S, Xiong X, Sun Y. Functional characterization of SOX2 as an anticancer target. Signal Transduct Target Ther. 2020;5(1):135.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2883_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1158\/jcr.1925.148","volume":"9","author":"O Warburg","year":"1925","unstructured":"Warburg O. The metabolism of carcinoma cells. Cancer Res. 1925;9(1):148\u201363.","journal-title":"Cancer Res"},{"issue":"1","key":"2883_CR42","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.1038\/s41467-020-18954-z","volume":"11","author":"S Valle","year":"2020","unstructured":"Valle S, Alcala S, Martin-Hijano L, Cabezas-Sainz P, Navarro D, Munoz ER, et al. Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells. Nat Commun. 2020;11(1):5265.","journal-title":"Nat Commun"},{"issue":"10","key":"2883_CR43","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.celrep.2015.08.006","volume":"12","author":"M Cioffi","year":"2015","unstructured":"Cioffi M, Vallespinos-Serrano M, Trabulo SM, Fernandez-Marcos PJ, Firment AN, Vazquez BN, et al. MiR-93 controls adiposity via inhibition of Sirt7 and Tbx3. Cell Rep. 2015;12(10):1594\u2013605.","journal-title":"Cell Rep"},{"key":"2883_CR44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.biomaterials.2015.02.004","volume":"52","author":"L Jiang","year":"2015","unstructured":"Jiang L, Li L, He X, Yi Q, He B, Cao J, et al. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. Biomaterials. 2015;52:126\u201339.","journal-title":"Biomaterials"},{"issue":"1","key":"2883_CR45","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162(1):156\u20139.","journal-title":"Anal Biochem"},{"issue":"3","key":"2883_CR46","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","volume":"7","author":"C Trapnell","year":"2012","unstructured":"Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 2012;7(3):562\u201378.","journal-title":"Nat Protoc"},{"issue":"3","key":"2883_CR47","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10(3):R25.","journal-title":"Genome Biol"},{"issue":"16","key":"2883_CR48","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"issue":"Database issue","key":"2883_CR49","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/nar\/gkt1196","volume":"42","author":"P Flicek","year":"2014","unstructured":"Flicek P, Amode MR, Barrell D, Beal K, Billis K, Brent S, et al. Ensembl 2014. Nucleic Acids Res. 2014;42(Database issue):749\u201355.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02883-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-023-02883-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02883-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T04:44:46Z","timestamp":1701146686000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-023-02883-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2883"],"URL":"https:\/\/doi.org\/10.1186\/s13046-023-02883-y","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"9 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The collection and propagation of PDAC patient samples were performed at different research institutions while adhering to ethical guidelines and informed consent procedures. The Spanish National Cancer Research Centre (CNIO), Madrid, Spain (reference 1204090835CHMH), the ARC-Net Biobank of the University and Hospital Trust of Verona, Italy (approved by the Verona University Hospital Ethics Committee, Program 1885 protocol 52438 23\/11\/2010, program 2172 protocol 26773 23\/05\/2012), and the Shanghai Jiao Tong University School of Medicine, Shanghai, China (reference 2013\u20130905-70) obtained appropriate informed consent from each patient before collecting samples.All animal procedures involving mice were performed in compliance with regulations concerning animals used in scientific research. The animal procedures in the UK were conducted under Project License PPL70\/8129, while the Shanghai Jiao Tong University School of Medicine approved the project under project approval A-2020\u2013004.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}